4.6 Review

Death in the fast lane: what's next for necroptosis?

Journal

FEBS JOURNAL
Volume 283, Issue 14, Pages 2616-2625

Publisher

WILEY-BLACKWELL
DOI: 10.1111/febs.13520

Keywords

apoptosis; caspase-8; MLKL; necroptosis; RIPK1; RIPK3

Funding

  1. NCI NIH HHS [R21 CA185681] Funding Source: Medline
  2. NIAID NIH HHS [R01 AI108685] Funding Source: Medline

Ask authors/readers for more resources

Necroptosis is a form of programmed cell death that is both mechanistically and morphologically distinct from apoptosis, the canonical mechanism of cell suicide. Although early descriptions of necroptosis date back decades, the last 5 years have seen a proliferation of studies of this process. This surge in interest has included the recent publication of several excellent, in-depth reviews of the literature [Chan FK-M et al. (2014) Annu Rev Immunol 33, 141210135520002; Weinlich R & Green DR (2014) Mol Cell 56, 469-480; Silke J et al. (2015) Nat Immunol 16, 689-697; Linkermann A & Green DR (2014) N Engl J Med 370, 455-465]. Rather than contribute another summary to this well-summarized field, in this Minireview I will briefly discuss key recent findings, then touch on some of the major outstanding questions -the known unknowns - that remain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available